Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06072287
Other study ID # HR/DP-22/23-36320
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date June 28, 2023
Est. completion date January 10, 2024

Study information

Verified date September 2023
Source King's College London
Contact Natasha Seaton, MSc
Phone 0207 188 1189
Email LTC-study@kcl.ac.uk
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Psychological distress (anxiety and depression) is common in and experienced differently by people living with long-term health conditions (LTCs). Being able to measure whether psychological distress is related to living with a LTC would allow researchers and clinicians to provide interventions specifically tailored to the challenges of living with a LTC and therefore provide the most appropriate support for these patients. Such a measure would also be useful in research to identify the presence of illness-related distress in different patient groups. This project will therefore create a new measure of illness-related distress that has applications for both research and clinical practice. This will involve the psychometric validation of the new illness-related distress measure to test how valid and reliable the measure is. The aim of the project is to provide initial validation of the Illness Related Distress Scale in a community sample, recruited through online platforms. The objective of the study is to gather initial validity and reliability data for the scale.


Description:

Background: see brief summary Project information: This study will be conducted online with participants from the UK. A series of standardised questionnaires will be used alongside the new questionnaire. Participants will be those who self-select to complete our survey by responding to advertisements. The invitation will include a link to the Qualtrics survey which includes the Participant Information Sheet, Eligibility Screening, Consent Form and Baseline Questionnaire. After completing eligibility screening and consent, participants will complete the baseline questionnaire which will include brief demographics (highest education level, long-term condition diagnoses, ethnicity age and gender), the new measure we are testing (the Illness Related Distress Scale), as well as the Patient Health Questionnaire (PHQ-8), Generalised Anxiety Disorder Scale (GAD-7), the Work and Social Adjustment Scale (WSAS). The baseline questionnaire will only include the Inflammatory Bowel Disease Distress Scale (IBD-DS) and Diabetes Distress Scale (DDS) if participants indicate that they have a diagnosis of the relevant condition. At 1 week follow-up, participants will be sent a Qualtrics link to complete our 1-week follow-up questionnaire which will include the new Illness-Related Distress Scale only. Participants: We are aiming to recruit 600-700 participants for the study.


Recruitment information / eligibility

Status Recruiting
Enrollment 600
Est. completion date January 10, 2024
Est. primary completion date December 31, 2023
Accepts healthy volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Over the age of 18 - Self-reported diagnosis of a Long-Term Condition - UK resident - Possession of an email address to enable all study procedures - Sufficient command of written and spoken English to understand study procedures Exclusion Criteria: - Under the age of 18 - Not living in the UK - No self-reported diagnosis of an LTC - Inability to complete questionnaires in English

Study Design


Related Conditions & MeSH terms

  • AIDS
  • Amyotrophic Lateral Sclerosis
  • Anemia, Sickle Cell
  • Arthritis
  • Asthma
  • Atrial Fibrillation
  • Cancer
  • Celiac Disease
  • Cerebrovascular Disorders
  • CKD
  • Copd
  • Cystic Fibrosis
  • Dementia
  • Diabetes
  • Eczema
  • Endometriosis
  • Epilepsy
  • Fibromyalgia
  • Heart Diseases
  • Heart Failure
  • Hepatitis
  • Hidradenitis
  • Hidradenitis Suppurativa
  • High Blood Pressure
  • Hiv
  • Hypertension
  • IBD
  • IBS
  • Liver Diseases
  • Long COVID
  • Lupus Erythematosus
  • ME/CFS
  • Migraine
  • MND (Motor Neurone DIsease)
  • Motor Neuron Disease
  • Multiple Sclerosis
  • Nervous System Diseases
  • Neurological Disorder
  • Obesity
  • Osteoarthritis
  • Osteoporosis
  • Pain
  • Parkinson Disease
  • PCOS
  • Postural Orthostatic Tachycardia Syndrome
  • Rheumatoid Arthritis
  • Sickle Cell Disease
  • Spondylitis
  • Stroke
  • Tachycardia

Intervention

Diagnostic Test:
Living with LTC Questionnaire
A questionnaire that will ask about demographic information, mental wellbeing and distress related to chronic illness.

Locations

Country Name City State
United Kingdom King's College London London

Sponsors (1)

Lead Sponsor Collaborator
King's College London

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary Illness-related distress 31 item questionnaire developed by the research team designed to assess illness-related distresss. Week 0 and Week 1
Secondary Depression Eight-item Patient Health Questionnaire - 8 (PHQ-8) Minimum=0, maximum=24, with higher scores indicating greater depression. Week 0
Secondary Anxiety Seven-item Generalised Anxiety Disorder Scale (GAD-7). Minimum=0, maximum=21, with higher scores indicating greater anxiety. Week 0
Secondary Functional impairment Five-item Work and Social Adjustment Scale (WSAS). Minimum=0, maximum=50, with higher scores indicating greater functional impairment. Week 0
Secondary Diabetes Related Distress Scale Diabetes Related Distress Scale (DDS-17), a 17 item self-report diabetes related distress questionnaire. Minimum=17, maximum=102, with higher scores indicating greater distress. Week 0
Secondary IBD Distress Scale IBD Distress Scale, a 28 item self-report IBD related distress questionnaire. Minimum=29, maximum=145, with higher scores indicating greater distress. Week 0
Secondary Cognitive and Behavioural Responses to Symptoms Cognitive Behavioural Responses to Symptoms Questionnaire, 40 item self-report questionnaire consisting of seven subscales with items scored on a 5 point scale. Higher scores correspond with stronger presence of the specific cognitive/behavioural response. The seven subscales refer to 1) fear avoidance, 2) catastrophising, 3) damage beliefs, 4) embarassment avoidance 5) symptom focussing 6) all-or-nothing behaviour and 7) avoidance/resting behaviour. Week 0
See also
  Status Clinical Trial Phase
Recruiting NCT04101669 - EndoBarrier System Pivotal Trial(Rev E v2) N/A
Recruiting NCT04243317 - Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults N/A
Terminated NCT03772886 - Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball N/A
Completed NCT03640442 - Modified Ramped Position for Intubation of Obese Females. N/A
Completed NCT04506996 - Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2 N/A
Recruiting NCT06019832 - Analysis of Stem and Non-Stem Tibial Component N/A
Active, not recruiting NCT05891834 - Study of INV-202 in Patients With Obesity and Metabolic Syndrome Phase 2
Active, not recruiting NCT05275959 - Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI) N/A
Recruiting NCT04575194 - Study of the Cardiometabolic Effects of Obesity Pharmacotherapy Phase 4
Completed NCT04513769 - Nutritious Eating With Soul at Rare Variety Cafe N/A
Withdrawn NCT03042897 - Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer N/A
Completed NCT03644524 - Heat Therapy and Cardiometabolic Health in Obese Women N/A
Recruiting NCT05917873 - Metabolic Effects of Four-week Lactate-ketone Ester Supplementation N/A
Active, not recruiting NCT04353258 - Research Intervention to Support Healthy Eating and Exercise N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Recruiting NCT03227575 - Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control N/A
Completed NCT01870947 - Assisted Exercise in Obese Endometrial Cancer Patients N/A
Recruiting NCT06007404 - Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
Recruiting NCT05972564 - The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function Phase 1/Phase 2
Recruiting NCT05371496 - Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction Phase 2

External Links